Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
MOTS-C directly improves mitochondrial function and metabolic efficiency
Niedzwiecki, M
At present, DSIP remains an experimental peptide with limited high-quality human data, and it has not been approved as a standard treatment for insomnia or psychiatric conditions
Intranasal delivery, bypassing the BBB via neural pathways, has emerged as an alternative, particularly effective for peptide-modified or mucoadhesive NPs delivering hydrophilic or biologic agents [63]
Acknowledgements The labs of A.B
In addition to GLP-1R/GCGR dual agonists, a chimeric peptide as dual GLP-1/GIP receptor agonists has been developed, showing enhanced therapeutic potential for obesity and related comorbidities
US$ 25.57
US$ 20.56
US$ 25.45
US$ 27.19
US$ 20.52
